Annual D&A
$0.00$0.000.00%
Summary
- Current Value
- As of today, RPRX annual D&A is $0.00, unchanged on
- Historical Performance
- RPRX annual D&A is down -100.00% over the past 3 years, and down -100.00% over the past 5 years
- All-Time High Comparison
- RPRX annual D&A is currently -100.00% below its historical high of $33.27M set on
- 3-Year Low Comparison
- RPRX annual D&A vs 3-year low value is unknown
- Sector Comparison
- RPRX annual D&A is higher than 1.25% of companies in Healthcare sector
Depreciation & Amortization Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual D&A | $0.00 | 0.0% | -100.0% | -100.0% | – | |
| Quarterly D&A | $1.28M | – | +100.0% | -78.0% | -80.7% | |
| TTM D&A | $1.28M | – | -88.9% | -94.5% | -80.7% | |
| Price | $40.26 | +36.5% | +2.7% | -18.6% | – | |
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Annual Total Expenses | $1.40B | +15.2% | -15.9% | +362.9% | +31.1% | |
| Annual Operating Expenses | -$1.29B | +13.4% | -254.6% | +50.7% | -62.7% | |
| Annual Revenue | $2.26B | -3.9% | -1.1% | +24.8% | +37.0% |
Depreciation & Amortization Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $5.67M | N/A | -100.0% |
| 5Y | $23.06M | N/A | -100.0% |
| All | $33.27M | -100.0% |
Depreciation & Amortization Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Depreciation & Amortization History
| Year | Value | Change |
|---|---|---|
| $0.00 | 0.0% | |
| $0.00 | -100.0% | |
| $5.67M | -75.3% | |
| $23.00M | -0.3% |
| Year | Value | Change |
|---|---|---|
| $23.06M | -3.6% | |
| $23.92M | -28.1% | |
| $33.27M | 0.0% | |
| $33.27M | - |
FAQ
What is the current annual D&A of RPRX?
As of today, RPRX annual D&A is $0.00
What is 1-year change in RPRX annual D&A?
RPRX annual D&A has remained unchanged year-over-year
What is 3-year change in RPRX annual D&A?
RPRX annual D&A is down -100.00% over the past 3 years
How far is RPRX annual D&A from its all-time high?
RPRX annual D&A is currently -100.00% below its historical high of $33.27M set on December 31, 2017
How does RPRX annual D&A rank versus sector peers?
RPRX annual D&A is higher than 1.25% of companies in Healthcare sector
When is RPRX next annual earnings release?
The next annual earnings release for RPRX is on
Quarterly D&A
$1.28M
Summary
- Current Value
- As of today, RPRX quarterly D&A is $1.28M, with unknown change on
- Historical Performance
- RPRX quarterly D&A 1-year change is unknown, and up +100.00% over the past 3 years
- All-Time High Comparison
- RPRX quarterly D&A is currently -80.65% below its historical high of $6.60M set on
- 3-Year Low Comparison
- RPRX quarterly D&A vs 3-year low value is unknown
- Sector Comparison
- RPRX quarterly D&A is higher than 61.34% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly D&A | $1.28M | – | – | +100.0% | -78.0% | |
| Annual D&A | $0.00 | – | 0.0% | -100.0% | -100.0% | |
| TTM D&A | $1.28M | – | – | -88.9% | -94.5% | |
| Price | $40.26 | +11.8% | +36.5% | +2.7% | -18.6% | |
| Quarterly SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly Total Expenses | $321.07M | -41.5% | +1450.9% | -25.5% | +29.6% | |
| Quarterly Operating Expenses | $180.86M | +186.2% | +124.6% | +194.1% | +135.4% | |
| Quarterly Revenue | $609.29M | +5.3% | +7.9% | +6.3% | +13.2% |
Quarterly D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.28M | at high | |
| 3Y | $1.28M | at high | |
| 5Y | $5.80M | -78.0% | |
| All | $6.60M | -80.7% |
Quarterly D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.28M | at low | |
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
Quarterly D&A History
FAQ
What is the current quarterly D&A of RPRX?
As of today, RPRX quarterly D&A is $1.28M
What is RPRX quarterly D&A most recent change?
RPRX quarterly D&A change on September 30, 2025 is unknown
What is 1-year change in RPRX quarterly D&A?
RPRX quarterly D&A 1-year change is unknown
How far is RPRX quarterly D&A from its all-time high?
RPRX quarterly D&A is currently -80.65% below its historical high of $6.60M set on March 31, 2019
How does RPRX quarterly D&A rank versus sector peers?
RPRX quarterly D&A is higher than 61.34% of companies in Healthcare sector
When is RPRX next earnings release?
The next earnings release for RPRX is on
TTM D&A
$1.28M
Summary
- Current Value
- As of today, RPRX TTM D&A is $1.28M, with unknown change on
- Historical Performance
- RPRX TTM D&A 1-year change is unknown, and down -88.86% over the past 3 years
- All-Time High Comparison
- RPRX TTM D&A is currently -94.66% below its historical high of $23.92M set on
- 3-Year Low Comparison
- RPRX TTM D&A vs 3-year low value is unknown
- Sector Comparison
- RPRX TTM D&A is higher than 40.90% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM D&A | $1.28M | – | – | -88.9% | -94.5% | |
| Annual D&A | $0.00 | – | 0.0% | -100.0% | -100.0% | |
| Quarterly D&A | $1.28M | – | – | +100.0% | -78.0% | |
| Price | $40.26 | +11.8% | +36.5% | +2.7% | -18.6% | |
| TTM SG&A | $9.85B | +2273.2% | +4220.1% | +4824.8% | +6271.1% | |
| TTM Revenue | $2.35B | +1.9% | +3.7% | +4.6% | +17.1% |
TTM D&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.28M | at high | |
| 3Y | $5.67M | N/A | -77.5% |
| 5Y | $23.06M | N/A | -94.5% |
| All | $23.92M | -94.7% |
TTM D&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.28M | at low | |
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
TTM D&A History
FAQ
What is the current TTM D&A of RPRX?
As of today, RPRX TTM D&A is $1.28M
What is RPRX TTM D&A most recent change?
RPRX TTM D&A change on September 30, 2025 is unknown
What is 1-year change in RPRX TTM D&A?
RPRX TTM D&A 1-year change is unknown
How far is RPRX TTM D&A from its all-time high?
RPRX TTM D&A is currently -94.66% below its historical high of $23.92M set on December 31, 2019
How does RPRX TTM D&A rank versus sector peers?
RPRX TTM D&A is higher than 40.90% of companies in Healthcare sector
When is RPRX next earnings release?
The next earnings release for RPRX is on
Data Sources & References
- RPRX Official Website www.royaltypharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1802768/000180276825000114/0001802768-25-000114-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1802768/000180276825000010/0001802768-25-000010-index.htm
- RPRX Profile on Yahoo Finance finance.yahoo.com/quote/RPRX
- RPRX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rprx